The global Inhalers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Inhalers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Inhalers is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Inhalers include GlaxoSmithKline, Merck, AstraZeneca, Boehringer-Ingelheim, 3M, Teva, Sunovion Pharmaceuticals, Aristopharma and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Inhalers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhalers.

Report Scope

The Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inhalers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Inhalers Market Report

Report Metric	Details
Report Name	Inhalers Market
Segment by Type	Metered Dose Inhalers Dry Powder Inhalers Nasal Inhalers Other
Segment by Application	Hospital Clinic Respiratory Care Centers Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	GlaxoSmithKline, Merck, AstraZeneca, Boehringer-Ingelheim, 3M, Teva, Sunovion Pharmaceuticals, Aristopharma, Novartis, Vectura Group, MannKind, Respirices, Orion Pharm, Hovione
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhalers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhalers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Inhalers Market report?

Ans: The main players in the Inhalers Market are GlaxoSmithKline, Merck, AstraZeneca, Boehringer-Ingelheim, 3M, Teva, Sunovion Pharmaceuticals, Aristopharma, Novartis, Vectura Group, MannKind, Respirices, Orion Pharm, Hovione

What are the Application segmentation covered in the Inhalers Market report?

Ans: The Applications covered in the Inhalers Market report are Hospital, Clinic, Respiratory Care Centers, Others

What are the Type segmentation covered in the Inhalers Market report?

Ans: The Types covered in the Inhalers Market report are Metered Dose Inhalers, Dry Powder Inhalers, Nasal Inhalers, Other

1 Inhalers Market Overview

1.1 Product Overview and Scope of Inhalers

1.2 Inhalers Segment by Type

1.2.1 Global Inhalers Market Value Comparison by Type (2024-2030)

1.2.2 Metered Dose Inhalers

1.2.3 Dry Powder Inhalers

1.2.4 Nasal Inhalers

1.2.5 Other

1.3 Inhalers Segment by Application

1.3.1 Global Inhalers Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Respiratory Care Centers

1.3.5 Others

1.4 Global Inhalers Market Size Estimates and Forecasts

1.4.1 Global Inhalers Revenue 2019-2030

1.4.2 Global Inhalers Sales 2019-2030

1.4.3 Global Inhalers Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Inhalers Market Competition by Manufacturers

2.1 Global Inhalers Sales Market Share by Manufacturers (2019-2024)

2.2 Global Inhalers Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Inhalers Average Price by Manufacturers (2019-2024)

2.4 Global Inhalers Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Inhalers, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Inhalers, Product Type & Application

2.7 Inhalers Market Competitive Situation and Trends

2.7.1 Inhalers Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Inhalers Players Market Share by Revenue

2.7.3 Global Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Inhalers Retrospective Market Scenario by Region

3.1 Global Inhalers Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Inhalers Global Inhalers Sales by Region: 2019-2030

3.2.1 Global Inhalers Sales by Region: 2019-2024

3.2.2 Global Inhalers Sales by Region: 2025-2030

3.3 Global Inhalers Global Inhalers Revenue by Region: 2019-2030

3.3.1 Global Inhalers Revenue by Region: 2019-2024

3.3.2 Global Inhalers Revenue by Region: 2025-2030

3.4 North America Inhalers Market Facts & Figures by Country

3.4.1 North America Inhalers Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Inhalers Sales by Country (2019-2030)

3.4.3 North America Inhalers Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Inhalers Market Facts & Figures by Country

3.5.1 Europe Inhalers Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Inhalers Sales by Country (2019-2030)

3.5.3 Europe Inhalers Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Inhalers Market Facts & Figures by Country

3.6.1 Asia Pacific Inhalers Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Inhalers Sales by Country (2019-2030)

3.6.3 Asia Pacific Inhalers Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Inhalers Market Facts & Figures by Country

3.7.1 Latin America Inhalers Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Inhalers Sales by Country (2019-2030)

3.7.3 Latin America Inhalers Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Inhalers Market Facts & Figures by Country

3.8.1 Middle East and Africa Inhalers Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Inhalers Sales by Country (2019-2030)

3.8.3 Middle East and Africa Inhalers Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Inhalers Sales by Type (2019-2030)

4.1.1 Global Inhalers Sales by Type (2019-2024)

4.1.2 Global Inhalers Sales by Type (2025-2030)

4.1.3 Global Inhalers Sales Market Share by Type (2019-2030)

4.2 Global Inhalers Revenue by Type (2019-2030)

4.2.1 Global Inhalers Revenue by Type (2019-2024)

4.2.2 Global Inhalers Revenue by Type (2025-2030)

4.2.3 Global Inhalers Revenue Market Share by Type (2019-2030)

4.3 Global Inhalers Price by Type (2019-2030)

5 Segment by Application

5.1 Global Inhalers Sales by Application (2019-2030)

5.1.1 Global Inhalers Sales by Application (2019-2024)

5.1.2 Global Inhalers Sales by Application (2025-2030)

5.1.3 Global Inhalers Sales Market Share by Application (2019-2030)

5.2 Global Inhalers Revenue by Application (2019-2030)

5.2.1 Global Inhalers Revenue by Application (2019-2024)

5.2.2 Global Inhalers Revenue by Application (2025-2030)

5.2.3 Global Inhalers Revenue Market Share by Application (2019-2030)

5.3 Global Inhalers Price by Application (2019-2030)

6 Key Companies Profiled

6.1 GlaxoSmithKline

6.1.1 GlaxoSmithKline Corporation Information

6.1.2 GlaxoSmithKline Description and Business Overview

6.1.3 GlaxoSmithKline Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.1.4 GlaxoSmithKline Inhalers Product Portfolio

6.1.5 GlaxoSmithKline Recent Developments/Updates

6.2 Merck

6.2.1 Merck Corporation Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Merck Inhalers Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 AstraZeneca

6.3.1 AstraZeneca Corporation Information

6.3.2 AstraZeneca Description and Business Overview

6.3.3 AstraZeneca Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.3.4 AstraZeneca Inhalers Product Portfolio

6.3.5 AstraZeneca Recent Developments/Updates

6.4 Boehringer-Ingelheim

6.4.1 Boehringer-Ingelheim Corporation Information

6.4.2 Boehringer-Ingelheim Description and Business Overview

6.4.3 Boehringer-Ingelheim Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Boehringer-Ingelheim Inhalers Product Portfolio

6.4.5 Boehringer-Ingelheim Recent Developments/Updates

6.5 3M

6.5.1 3M Corporation Information

6.5.2 3M Description and Business Overview

6.5.3 3M Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.5.4 3M Inhalers Product Portfolio

6.5.5 3M Recent Developments/Updates

6.6 Teva

6.6.1 Teva Corporation Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Teva Inhalers Product Portfolio

6.6.5 Teva Recent Developments/Updates

6.7 Sunovion Pharmaceuticals

6.6.1 Sunovion Pharmaceuticals Corporation Information

6.6.2 Sunovion Pharmaceuticals Description and Business Overview

6.6.3 Sunovion Pharmaceuticals Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sunovion Pharmaceuticals Inhalers Product Portfolio

6.7.5 Sunovion Pharmaceuticals Recent Developments/Updates

6.8 Aristopharma

6.8.1 Aristopharma Corporation Information

6.8.2 Aristopharma Description and Business Overview

6.8.3 Aristopharma Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Aristopharma Inhalers Product Portfolio

6.8.5 Aristopharma Recent Developments/Updates

6.9 Novartis

6.9.1 Novartis Corporation Information

6.9.2 Novartis Description and Business Overview

6.9.3 Novartis Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Novartis Inhalers Product Portfolio

6.9.5 Novartis Recent Developments/Updates

6.10 Vectura Group

6.10.1 Vectura Group Corporation Information

6.10.2 Vectura Group Description and Business Overview

6.10.3 Vectura Group Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Vectura Group Inhalers Product Portfolio

6.10.5 Vectura Group Recent Developments/Updates

6.11 MannKind

6.11.1 MannKind Corporation Information

6.11.2 MannKind Inhalers Description and Business Overview

6.11.3 MannKind Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.11.4 MannKind Inhalers Product Portfolio

6.11.5 MannKind Recent Developments/Updates

6.12 Respirices

6.12.1 Respirices Corporation Information

6.12.2 Respirices Inhalers Description and Business Overview

6.12.3 Respirices Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Respirices Inhalers Product Portfolio

6.12.5 Respirices Recent Developments/Updates

6.13 Orion Pharm

6.13.1 Orion Pharm Corporation Information

6.13.2 Orion Pharm Inhalers Description and Business Overview

6.13.3 Orion Pharm Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Orion Pharm Inhalers Product Portfolio

6.13.5 Orion Pharm Recent Developments/Updates

6.14 Hovione

6.14.1 Hovione Corporation Information

6.14.2 Hovione Inhalers Description and Business Overview

6.14.3 Hovione Inhalers Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Hovione Inhalers Product Portfolio

6.14.5 Hovione Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Inhalers Industry Chain Analysis

7.2 Inhalers Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Inhalers Production Mode & Process

7.4 Inhalers Sales and Marketing

7.4.1 Inhalers Sales Channels

7.4.2 Inhalers Distributors

7.5 Inhalers Customers

8 Inhalers Market Dynamics

8.1 Inhalers Industry Trends

8.2 Inhalers Market Drivers

8.3 Inhalers Market Challenges

8.4 Inhalers Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Boehringer Ingelheim

TEVA

Sunovion Pharmaceuticals

List of Tables

Table 1. Global Inhalers Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Inhalers Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Inhalers Market Competitive Situation by Manufacturers in 2023

Table 4. Global Inhalers Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Inhalers Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Inhalers Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Inhalers Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Inhalers Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Inhalers, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Inhalers, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Inhalers, Product Type & Application

Table 12. Global Key Manufacturers of Inhalers, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Inhalers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhalers as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Inhalers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Inhalers Sales by Region (2019-2024) & (K Units)

Table 18. Global Inhalers Sales Market Share by Region (2019-2024)

Table 19. Global Inhalers Sales by Region (2025-2030) & (K Units)

Table 20. Global Inhalers Sales Market Share by Region (2025-2030)

Table 21. Global Inhalers Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Inhalers Revenue Market Share by Region (2019-2024)

Table 23. Global Inhalers Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Inhalers Revenue Market Share by Region (2025-2030)

Table 25. North America Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Inhalers Sales by Country (2019-2024) & (K Units)

Table 27. North America Inhalers Sales by Country (2025-2030) & (K Units)

Table 28. North America Inhalers Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Inhalers Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Inhalers Sales by Country (2019-2024) & (K Units)

Table 32. Europe Inhalers Sales by Country (2025-2030) & (K Units)

Table 33. Europe Inhalers Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Inhalers Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Inhalers Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Inhalers Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Inhalers Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Inhalers Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Inhalers Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Inhalers Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Inhalers Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Inhalers Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Inhalers Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Inhalers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Inhalers Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Inhalers Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Inhalers Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Inhalers Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Inhalers Sales (K Units) by Type (2019-2024)

Table 51. Global Inhalers Sales (K Units) by Type (2025-2030)

Table 52. Global Inhalers Sales Market Share by Type (2019-2024)

Table 53. Global Inhalers Sales Market Share by Type (2025-2030)

Table 54. Global Inhalers Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Inhalers Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Inhalers Revenue Market Share by Type (2019-2024)

Table 57. Global Inhalers Revenue Market Share by Type (2025-2030)

Table 58. Global Inhalers Price (USD/Unit) by Type (2019-2024)

Table 59. Global Inhalers Price (USD/Unit) by Type (2025-2030)

Table 60. Global Inhalers Sales (K Units) by Application (2019-2024)

Table 61. Global Inhalers Sales (K Units) by Application (2025-2030)

Table 62. Global Inhalers Sales Market Share by Application (2019-2024)

Table 63. Global Inhalers Sales Market Share by Application (2025-2030)

Table 64. Global Inhalers Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Inhalers Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Inhalers Revenue Market Share by Application (2019-2024)

Table 67. Global Inhalers Revenue Market Share by Application (2025-2030)

Table 68. Global Inhalers Price (USD/Unit) by Application (2019-2024)

Table 69. Global Inhalers Price (USD/Unit) by Application (2025-2030)

Table 70. GlaxoSmithKline Corporation Information

Table 71. GlaxoSmithKline Description and Business Overview

Table 72. GlaxoSmithKline Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. GlaxoSmithKline Inhalers Product

Table 74. GlaxoSmithKline Recent Developments/Updates

Table 75. Merck Corporation Information

Table 76. Merck Description and Business Overview

Table 77. Merck Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Merck Inhalers Product

Table 79. Merck Recent Developments/Updates

Table 80. AstraZeneca Corporation Information

Table 81. AstraZeneca Description and Business Overview

Table 82. AstraZeneca Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. AstraZeneca Inhalers Product

Table 84. AstraZeneca Recent Developments/Updates

Table 85. Boehringer-Ingelheim Corporation Information

Table 86. Boehringer-Ingelheim Description and Business Overview

Table 87. Boehringer-Ingelheim Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Boehringer-Ingelheim Inhalers Product

Table 89. Boehringer-Ingelheim Recent Developments/Updates

Table 90. 3M Corporation Information

Table 91. 3M Description and Business Overview

Table 92. 3M Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. 3M Inhalers Product

Table 94. 3M Recent Developments/Updates

Table 95. Teva Corporation Information

Table 96. Teva Description and Business Overview

Table 97. Teva Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Teva Inhalers Product

Table 99. Teva Recent Developments/Updates

Table 100. Sunovion Pharmaceuticals Corporation Information

Table 101. Sunovion Pharmaceuticals Description and Business Overview

Table 102. Sunovion Pharmaceuticals Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Sunovion Pharmaceuticals Inhalers Product

Table 104. Sunovion Pharmaceuticals Recent Developments/Updates

Table 105. Aristopharma Corporation Information

Table 106. Aristopharma Description and Business Overview

Table 107. Aristopharma Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Aristopharma Inhalers Product

Table 109. Aristopharma Recent Developments/Updates

Table 110. Novartis Corporation Information

Table 111. Novartis Description and Business Overview

Table 112. Novartis Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Novartis Inhalers Product

Table 114. Novartis Recent Developments/Updates

Table 115. Vectura Group Corporation Information

Table 116. Vectura Group Description and Business Overview

Table 117. Vectura Group Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Vectura Group Inhalers Product

Table 119. Vectura Group Recent Developments/Updates

Table 120. MannKind Corporation Information

Table 121. MannKind Description and Business Overview

Table 122. MannKind Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. MannKind Inhalers Product

Table 124. MannKind Recent Developments/Updates

Table 125. Respirices Corporation Information

Table 126. Respirices Description and Business Overview

Table 127. Respirices Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Respirices Inhalers Product

Table 129. Respirices Recent Developments/Updates

Table 130. Orion Pharm Corporation Information

Table 131. Orion Pharm Description and Business Overview

Table 132. Orion Pharm Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Orion Pharm Inhalers Product

Table 134. Orion Pharm Recent Developments/Updates

Table 135. Hovione Corporation Information

Table 136. Hovione Description and Business Overview

Table 137. Hovione Inhalers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Hovione Inhalers Product

Table 139. Hovione Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Inhalers Distributors List

Table 143. Inhalers Customers List

Table 144. Inhalers Market Trends

Table 145. Inhalers Market Drivers

Table 146. Inhalers Market Challenges

Table 147. Inhalers Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Inhalers

Figure 2. Global Inhalers Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Inhalers Market Share by Type in 2023 & 2030

Figure 4. Metered Dose Inhalers Product Picture

Figure 5. Dry Powder Inhalers Product Picture

Figure 6. Nasal Inhalers Product Picture

Figure 7. Other Product Picture

Figure 8. Global Inhalers Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Inhalers Market Share by Application in 2023 & 2030

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Respiratory Care Centers

Figure 13. Others

Figure 14. Global Inhalers Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Inhalers Market Size (2019-2030) & (US$ Million)

Figure 16. Global Inhalers Sales (2019-2030) & (K Units)

Figure 17. Global Inhalers Average Price (USD/Unit) & (2019-2030)

Figure 18. Inhalers Report Years Considered

Figure 19. Inhalers Sales Share by Manufacturers in 2023

Figure 20. Global Inhalers Revenue Share by Manufacturers in 2023

Figure 21. The Global 5 and 10 Largest Inhalers Players: Market Share by Revenue in 2023

Figure 22. Inhalers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 23. Global Inhalers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Inhalers Sales Market Share by Country (2019-2030)

Figure 25. North America Inhalers Revenue Market Share by Country (2019-2030)

Figure 26. U.S. Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Inhalers Sales Market Share by Country (2019-2030)

Figure 29. Europe Inhalers Revenue Market Share by Country (2019-2030)

Figure 30. Germany Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Inhalers Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Inhalers Revenue Market Share by Region (2019-2030)

Figure 37. China Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Taiwan Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Indonesia Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Thailand Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Malaysia Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Philippines Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Inhalers Sales Market Share by Country (2019-2030)

Figure 48. Latin America Inhalers Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Inhalers Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Inhalers Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Inhalers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Inhalers by Type (2019-2030)

Figure 58. Global Revenue Market Share of Inhalers by Type (2019-2030)

Figure 59. Global Inhalers Price (USD/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Inhalers by Application (2019-2030)

Figure 61. Global Revenue Market Share of Inhalers by Application (2019-2030)

Figure 62. Global Inhalers Price (USD/Unit) by Application (2019-2030)

Figure 63. Inhalers Value Chain

Figure 64. Inhalers Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions